Baird lowered the firm’s price target on Dentsply Sirona (XRAY) to $24 from $31. The firm said with implant and equipment pressures continuing, shares were likely going to be down today.

Needham analyst David Saxon maintained a Buy rating on DENTSPLY SIRONA (XRAY – Research Report) today and set a price target of $23.00. David Saxon has given his Buy rating due to a combination ...

Oct 24 (Reuters) - (This Oct. 24 story has been corrected to say that Dentsply Sirona suspended sales of its 'Byte' teeth aligners, not all aligners in the headline) Dentsply Sirona (XRAY.O ...

CHARLOTTE, N.C., Oct. 24, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY), today announced the voluntary suspension of sales and marketing of ...

Dentsply Sirona's Q3 earnings beat estimates, but a $495M goodwill impairment and lower sales outlook weigh on results. Dentsply revises FY24 outlook, citing market pressures and Byte-related ...

DENTSPLY SIRONA Inc (Symbol: XRAY) presently has an above average rank, in the top 50% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further ...

Serona Elton, University of Miami music industry professor, said coming out of the pandemic, live music is just a bigger part of our lives and our budgets. “We’ve now come out of revenge ...

DENTSPLY SIRONA Inc. XRAY is scheduled to release third-quarter 2024 results on Nov. 7, before the opening bell. In the last reported quarter, the company’s earnings missed the Zacks Consensus ...

Dentsply Sirona said it voluntarily suspended sales of its dental Byte Aligners and Impression Kits, a decision made in consultation with the Food and Drug Administration. The manufacturer and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...